If you’ve been asking “what is the best test to check for leaky gut,” you’re not alone, and the answer is more nuanced than most practitioners let on. A client came to me a few years ago carrying a folder. Inside were three different test recommendations from three different providers: a blood draw for serum zonulin, a GI-MAP order from a functional medicine doctor, and a screenshot of a direct-to-consumer “gut barrier panel” she’d found online. All three claimed to test for the same thing. Not one of the practitioners had explained what made their preferred test better than the others.
At All Purpose Nutrition, this is one of the first questions new clients with chronic gut symptoms ask: “Which leaky gut test should I actually get?” It’s fair, and the honest answer is that it depends on what you’re trying to learn. Intestinal permeability is a real, measurable biological phenomenon. The confusion isn’t about whether it exists, it’s about which test captures it reliably enough to be worth ordering. This guide walks through each option, what it actually measures, how strong the evidence behind it is, and when it makes sense to use it.
Why testing for leaky gut is more complicated than it sounds
The gut lining is designed to be selectively permeable. It lets nutrients through while keeping pathogens, toxins, and undigested food particles out. That selectivity depends on tight junction proteins holding the epithelial cells together. When those junctions break down, larger molecules can cross into the bloodstream, triggering immune responses and systemic inflammation. That’s increased intestinal permeability, and it’s a measurable finding that shows up alongside conditions like celiac disease, Crohn’s, and IBS.
What it isn’t is a standalone diagnosis. Most major gastroenterology societies don’t recognize “leaky gut syndrome” as a diagnosable condition on its own. Increased permeability is a feature of other diseases, not a disease by itself. An AGA-linked review makes this clear: no validated test currently exists to diagnose the condition from symptoms, blood work, or stool studies alone. Understanding that upfront protects you from over-interpreting any single result.
The most direct way to measure gut barrier function is an intestinal biopsy analyzed using a device called an Ussing chamber, which assesses electrical resistance and ion transport across actual gut tissue. This approach is used in academic research settings and serves as the reference standard against which all other tests are compared. It requires endoscopy or colonoscopy and specialized lab equipment, though, so clinicians use proxy markers instead: sugar probes in urine, proteins in blood, microbial findings in stool. Each captures a different piece of the picture, and none match the biopsy perfectly.
The lactulose-mannitol urine test: is this the best gut permeability test for GI conditions?
The dual-sugar probe method is the most studied noninvasive approach for measuring intestinal permeability, and it works through a straightforward principle. The patient drinks a solution containing two sugars: mannitol, which is small enough to be absorbed normally through healthy epithelial cells, and lactulose, a larger molecule that shouldn’t cross easily if the gut barrier is intact. Urine is then collected over a set period and the lactulose-to-mannitol ratio is calculated. Picture filling a wall with two different-sized balls and measuring how many of the larger ones made it to the other side.
The accuracy data is genuinely encouraging in specific conditions. For celiac disease, pooled sensitivity runs around 83% and specificity around 70%, with an AUC of 0.88. For Crohn’s disease, one study reported 89.5% sensitivity and 100% specificity at a specific cutoff. Those are meaningful numbers. The honest caveat is that performance varies significantly by disease, patient population, and the cutoff value used. A 1988 study published in Gut found low diagnostic sensitivity outside of relapsing patients, and a later meta-analysis described the test as more useful for screening than definitive diagnosis.
For patients with a known or suspected GI condition, celiac, Crohn’s, or IBD, this gut permeability test provides a functional measure of how compromised the gut barrier actually is. The limitation is access. The lactulose-mannitol test isn’t offered by most standard labs, and the collection protocol requires careful timing and handling. For people going through general practitioners rather than academic medical centers, it’s rarely ordered, which is why the clinical landscape has shifted toward more accessible proxy markers.
Zonulin blood panels: why the results are trickier to interpret than the marketing suggests
Serum zonulin has become one of the most marketed biomarkers in the functional health space. Understanding why the evidence behind it is shaky requires a short detour into assay biology. Many commercial ELISA kits sold as “zonulin tests” don’t actually measure zonulin, technically known as prehaptoglobin-2. Independent studies using mass spectrometry and immunoblotting found that these kits appear to detect other proteins, most notably complement C3 fragments and properdin. When researchers tested the kits against recombinant pre-haptoglobin-2, the kits didn’t detect it at all.
This explains a frustrating pattern: serum zonulin results correlate poorly with functional permeability measures like the lactulose-mannitol ratio, even when they’re supposed to be measuring the same biological process. Reference ranges also vary dramatically between labs. One lab reports normal serum zonulin as below 38 ng/mL; another uses 34 ng/mL as its cutoff. These aren’t interchangeable numbers, and a “high” result from one platform may mean something completely different at another.
Stool zonulin is a different measurement, and the picture there is slightly more nuanced. Some evidence suggests fecal zonulin may be more sensitive to localized changes in gut barrier function than serum. The independent validation data is smaller and less consistent, but stool zonulin is generally treated as more clinically useful than its serum counterpart. If you already have a serum zonulin result in hand, don’t panic over a single elevated number. Look at the lab-specific reference range rather than a generic cutoff from a website, and treat the result as one piece of a larger clinical picture alongside symptoms, inflammatory markers, and digestive findings.
The GI-MAP with Zonulin add-on: more context for a clearer picture
The GI-MAP is a DNA-based stool test that uses quantitative PCR to identify and quantify pathogens including H. pylori, parasites, and bacteria. Beyond microbial findings, it reports digestive function markers like pancreatic elastase, immune markers like secretory IgA, and inflammation markers like calprotectin. The reason this breadth matters in a leaky gut conversation is that increased intestinal permeability rarely happens in isolation. It usually shows up alongside microbial imbalances, chronic inflammation, or active infection, and a test that only measures permeability misses the “why.”
The Zonulin add-on measures fecal zonulin within the same stool sample, so there’s no separate collection and no blood draw. What makes this clinically useful isn’t the zonulin result alone, it’s what that number looks like next to the rest of the panel. An H. pylori-positive result combined with elevated zonulin and low secretory IgA tells a very different story than elevated zonulin alongside normal microbial findings and normal calprotectin. The first suggests an active pathogen may be driving barrier disruption and immune suppression. The second is much harder to interpret without additional context. That’s the difference between a single data point and a clinical picture.
The GI-MAP with Zonulin is also collected at home using a leaky gut testing kit shipped directly to you, no lab visit, no blood draw, no inconvenient sugar-probe timing protocol. At All Purpose Nutrition, once the kit is returned and results are ready, a registered dietitian reviews them with you in a 1:1 coaching call and builds an individualized care plan around what the panel actually shows. The accessible collection paired with qualified interpretation is what makes this option clinically meaningful, rather than just another report sitting unopened in an inbox.
Direct-to-consumer gut barrier panels: real markers, limited validation
Several companies sell gut barrier panels online that measure combinations of zonulin, occludin, LPS antibodies, and secretory IgA. The markers themselves are real biological compounds. Occludin is a tight junction protein; LPS is a bacterial endotoxin that can enter circulation when the gut barrier is compromised. Measuring immune reactions to these compounds isn’t a meaningless idea. The problem is validation. Independent reviews consistently find that no commercial biomarker panel has been clinically validated to diagnose increased intestinal permeability from symptoms alone. Listing markers is not the same as clinical validation, and that distinction matters.
Brands like KBMO and Life Extension cite biomarker association studies in their marketing materials, but association studies and clinical diagnostic validation are not the same thing. A test can reproduce consistent numbers and still lack evidence that those numbers accurately identify a disease state or predict clinical outcomes. That doesn’t make every elevated marker meaningless, but it does mean a positive result requires careful interpretation rather than a self-diagnosis.
What is the best test to check for leaky gut? Matching the test to your situation
If you have a known GI condition like celiac disease, Crohn’s, or IBD, the lactulose-mannitol urine test provides the strongest functional data on gut barrier integrity when it’s accessible. Stool zonulin via the GI-MAP can supplement that picture, and invasive testing may already be part of your workup through a gastroenterologist. The permeability question fits into a broader disease management conversation rather than serving as the starting point.
If your symptoms are nonspecific, bloating, brain fog, food reactivity, or persistent fatigue, the GI-MAP with Zonulin add-on offers the most clinically useful combination. It doesn’t just flag elevated permeability; it identifies potential root causes alongside the permeability marker. A registered dietitian can use those combined findings to build a targeted nutrition protocol rather than guessing at causes from a single elevated number. Standalone serum zonulin is the weakest starting point given the assay variability problems described above.
If you’re considering a direct-to-consumer gut permeability test without a practitioner involved, proceed with caution. An elevated number without clinical context rarely produces a clear action plan. For clients who’ve already done extensive testing, beginning a gut healing protocol grounded in dietary changes, targeted supplements, and behavior shifts, then using symptoms as the primary feedback mechanism, is often a more practical path than adding another inconclusive data point. Testing is most valuable when the results will actually change what you do next.
The bottom line on leaky gut testing
No single test is perfect. The lactulose-mannitol urine test has the strongest research backing, particularly for known GI conditions, but it’s rarely accessible outside of research or specialty settings. The GI-MAP with Zonulin add-on is the most accessible and contextually rich option for most people, especially when reviewed by a clinician who can connect the dots between microbial findings, immune markers, and permeability data. Standalone serum zonulin is the weakest choice, given the assay problems that independent researchers have documented.
The most important variable isn’t which test you order. It’s whether someone with the right expertise reviews the results in the context of your full symptom picture, health history, and what you’re actually trying to address. If you want those results reviewed in that kind of depth, that’s exactly what the 1:1 coaching call at All Purpose Nutrition is designed for, you can book a free 15-minute discovery call to find out if it’s the right next step for your situation.
The goal isn’t a scary number on a lab report. It’s a clear enough picture that you know exactly what to do next, and someone in your corner who can help you get there.
Frequently asked questions
What is the best test to check for leaky gut?
The lactulose-mannitol urine test has the strongest clinical research behind it, particularly for people with diagnosed GI conditions like celiac disease or Crohn’s. For most people with nonspecific gut symptoms, the GI-MAP stool test with a Zonulin add-on is the most practical and contextually useful option available outside of a research setting, especially when reviewed by a qualified dietitian.
Can a blood test diagnose leaky gut?
Not reliably. Serum zonulin is widely marketed for this purpose, but independent research has shown that most commercial ELISA kits don’t actually measure zonulin accurately. Results vary dramatically between labs, and serum zonulin correlates poorly with functional permeability measures. It shouldn’t be used as a standalone diagnostic tool.
Are at-home leaky gut testing kits accurate?
At-home stool-based leaky gut testing kits like the GI-MAP use validated PCR technology and can produce meaningful data. Direct-to-consumer gut barrier panels that test for multiple antibody markers have less independent validation. The accuracy of any result depends significantly on how it’s interpreted, a detailed panel reviewed without clinical context produces limited actionable insight.
Does a negative leaky gut test rule out increased intestinal permeability?
Not necessarily. No available test has sufficient sensitivity to rule out increased permeability definitively, especially in mild or intermittent cases. A negative result on a single marker should be interpreted alongside symptoms, other lab findings, and clinical history rather than treated as conclusive.